Intellia Therapeutics Balance Sheet Health
Financial Health criteria checks 6/6
Intellia Therapeutics has a total shareholder equity of $1.1B and total debt of $0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are $1.3B and $250.8M respectively.
Key information
0%
Debt to equity ratio
US$0
Debt
Interest coverage ratio | n/a |
Cash | US$912.22m |
Equity | US$1.05b |
Total liabilities | US$250.81m |
Total assets | US$1.30b |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: 38I's short term assets ($998.3M) exceed its short term liabilities ($115.2M).
Long Term Liabilities: 38I's short term assets ($998.3M) exceed its long term liabilities ($135.6M).
Debt to Equity History and Analysis
Debt Level: 38I is debt free.
Reducing Debt: 38I has not had any debt for past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: 38I has sufficient cash runway for more than a year based on its current free cash flow.
Forecast Cash Runway: 38I has sufficient cash runway for 2.4 years if free cash flow continues to reduce at historical rates of 35.5% each year.